MAGEB3 Protein (His tag)

Produktnummer ABIN2725213

Produktdetails

Target: MAGEB3 (Melanoma Antigen Family B, 3 (MAGEB3))

Protein-Typ: Recombinant

Spezies: Human

Quelle: Escherichia coli (E. coli)

Aufreinigungstag / Konjugat: Dieses MAGEB3 Protein ist gelabelt mit His tag.

Applikation: Antibody Production (AbP), Standard (STD)

Produktmerkmale:

• Recombinant human MAGE-B3 (N-term HIS tag) protein expressed in E. coli.
• Produced with end-sequenced ORF clone

Reinheit: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Anwendungsinformationen

Applikationshinweise: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Kommentare:

The tag is located at the N-terminal.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 50 μg/mL

Buffer: 25 mM Tris, pH 8.0, 150 mM NaCl, 10 % glycerol, 1 % Sarkosyl.

Lagerung: -80 °C

Informationen zur Lagerung: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Antigendetails

Target: MAGEB3 (Melanoma Antigen Family B, 3 (MAGEB3))

Andere Bezeichnung: Mage-b3 (MAGEB3 Produkte)

Synonyme: CT3.5 Protein, Smage3 Protein, Mage-b3 Protein, Mage-ps1 Protein, Mage-rs3 Protein, RGD1562343 Protein, MAGEB3 Protein, MAGE family member B3 Protein, melanoma antigen, family B, 3 Protein, melanoma-associated antigen B3 Protein, MAGE family member B5 Protein, MAGEB3 Protein, Mageb3 Protein, LOC509870 Protein, MAGEB5 Protein

Hintergrund: This gene is a MAGE-B subfamily member of the MAGE gene family. MAGE family member proteins direct the expression of tumor antigens recognized on a human melanoma by autologous cytolytic T lymphocytes. There are two known clusters of MAGE genes on chromosome X. The members of the MAGE-A subfamily are located in the Xq28 region, while the members of the MAGE-B subfamily are clustered in the Xp21 region.

Molekulargewicht: 39 kDa

NCBI Accession: NP_002356